D. E. Shaw & Co., Inc. Biotechnology

D. E. Shaw & Co., Inc.

  • $107 Billion
  • Q3 2024

Stock List

Stock Option Type Value Options Held Last Trade Trade History
MRNA
Moderna, Inc.
PUT
$70 Million
1.05M
Q3 2024
New holding
MRNA
Moderna, Inc.
CALL
$45.3 Million
678K
Q3 2024
New holding
REGN
Regeneron Pharmaceuticals, Inc.
CALL
$44.7 Million
42.5K
Q3 2024
Added 4.65%
BNTX
Bio N Tech Se
PUT
$23.8 Million
201K
Q3 2024
Reduced 44.06%
ARGX
Argenx Se
PUT
$17.8 Million
32.9K
Q3 2024
Added 131.53%
MDGL
Madrigal Pharmaceuticals, Inc.
CALL
$11.4 Million
53.8K
Q2 2024
Reduced 84.38%
NVO
Novo Nordisk A S
CALL
$10.8 Million
90.5K
Q3 2024
Added 1839.15%
NVO
Novo Nordisk A S
PUT
$10.2 Million
85.8K
Q3 2024
Added 1839.15%
VRTX
Vertex Pharmaceuticals Inc
CALL
$6.56 Million
14.1K
Q3 2024
Reduced 18.61%
ALNY
Alnylam Pharmaceuticals, Inc.
CALL
$6.49 Million
23.6K
Q3 2024
Added 18.94%
BNTX
Bio N Tech Se
CALL
$5.11 Million
43K
Q3 2024
Reduced 44.06%
ARGX
Argenx Se
CALL
$3.85 Million
7.1K
Q3 2024
Added 131.53%
BPMC
Blueprint Medicines Corp
CALL
$3.62 Million
39.1K
Q3 2024
Reduced 15.51%
NVAX
Novavax Inc
CALL
$3.49 Million
277K
Q3 2024
Reduced 6.09%
VKTX
Viking Therapeutics, Inc.
CALL
$3.39 Million
53.5K
Q3 2024
Reduced 13.14%
AXSM
Axsome Therapeutics, Inc.
PUT
$2.83 Million
31.5K
Q3 2024
Reduced 54.22%
CRSP
Crispr Therapeutics Ag
CALL
$2.79 Million
59.3K
Q3 2024
Added 4.23%
BMRN
Biomarin Pharmaceutical Inc
PUT
$2.38 Million
33.8K
Q3 2024
Reduced 39.13%
CRSP
Crispr Therapeutics Ag
PUT
$1.67 Million
35.5K
Q3 2024
Added 4.23%
ZLAB
Zai Lab LTD
PUT
$1.67 Million
69K
Q3 2024
Reduced 49.16%
AXSM
Axsome Therapeutics, Inc.
CALL
$1.37 Million
15.3K
Q3 2024
Reduced 54.22%
BPMC
Blueprint Medicines Corp
PUT
$1.29 Million
13.9K
Q3 2024
Reduced 15.51%
ALNY
Alnylam Pharmaceuticals, Inc.
PUT
$1.27 Million
4.6K
Q3 2024
Added 18.94%
NTLA
Intellia Therapeutics, Inc.
PUT
$963,000
46.9K
Q3 2024
New holding
APLS
Apellis Pharmaceuticals, Inc.
CALL
$914,000
31.7K
Q4 2023
Reduced 16.18%
ASND
Ascendis Pharma A/S
CALL
$746,000
5K
Q3 2024
Reduced 67.9%
INSM
Insmed Inc
PUT
$730,000
10K
Q3 2024
Reduced 76.87%
SAGE
Sage Therapeutics, Inc.
PUT
$296,000
41.1K
Q3 2024
Added 99.53%
AKRO
Akero Therapeutics, Inc.
CALL
$258,000
9K
Q3 2024
Reduced 63.14%
ARWR
Arrowhead Pharmaceuticals, Inc.
PUT
$214,000
11.1K
Q4 2023
New holding
RVNC
Revance Therapeutics, Inc.
CALL
$77,000
30K
Q3 2024
Added 1689.41%
Filter Shares Options
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email